MedTrace Logo

Prevention Of Morbidity In Sickle Cell Disease Pilot Phase

NCT00415727 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2006-12-25

No results posted yet for this study

Summary

The hypothesis is that in sickle cell anaemia, nocturnal oxyhaemoglobin desaturation, is associated with low processing speed index, and this morbidity can be reduced with overnight auto Continuous Positive Airways Pressure and/or oxygen supplementation.

Conditions

  • Sickle Cell Anaemia

Interventions

DEVICE

auto Continuous Positive Airways Pressure (CPAP) with oxygen supplementation

Sponsors & Collaborators

  • Institute of Child Health

    lead OTHER

Principal Investigators

  • Fenella Kirkham, Dr · Institute Of Child Health and Great Ormond Street Hospital

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00415727 on ClinicalTrials.gov